Financials in USD. Standardized financial statements.
A compact view of how Profound Medical Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $16.38M | $10.17M | $7.20M | $6.68M | $6.87M | $7.30M | $4.17M | $1.91M | $4.90M | $0 |
| Revenue Growth? | +61.1% | +41.2% | +7.8% | -2.8% | -5.9% | +75.0% | +118.5% | -61.0% | 0.0% | 0.0% |
| Cost of Revenue? | $4.79M | $3.47M | $2.82M | $3.66M | $3.92M | $3.83M | $1.78M | $1.31M | $2.41M | $188,385 |
| Gross Profit? | $11.59M | $6.70M | $4.38M | $3.02M | $2.95M | $3.47M | $2.39M | $604,815 | $1.49M | -$188,385 |
| Gross Margin? | +70.8% | +65.9% | +60.9% | +45.2% | +43.0% | +47.6% | +57.3% | +31.7% | +30.4% | 0.0% |
| Operating Expenses? | $53.57M | $38.17M | $33.00M | $35.15M | $33.24M | $22.34M | $17.29M | $15.43M | $19.12M | $16.24M |
| Operating Income? | -$41.98M | -$31.47M | -$28.62M | -$32.13M | -$30.29M | -$18.86M | -$14.90M | -$14.83M | -$17.15M | -$16.24M |
| EBITDA? | -$41.41M | -$25.59M | -$26.78M | -$26.60M | -$28.65M | -$19.50M | -$12.53M | -$19.46M | -$16.46M | -$15.56M |
| Income Before Tax | -$43.06M | -$26.48M | -$28.70M | -$28.38M | -$30.59M | -$21.58M | -$15.07M | -$15.07M | -$18.75M | -$16.31M |
| Income Tax Expense | $256,411 | -$1,903 | -$128,000 | $287,000 | $105,000 | $45,000 | $147,000 | $169,441 | $74,123 | $14,054 |
| Net Income? | -$43.32M | -$26.48M | -$28.57M | -$28.67M | -$30.70M | -$21.62M | -$15.22M | -$15.24M | -$14.97M | -$12.15M |
| EPS? | $-1.43 | $-1.07 | $-1.35 | $-1.38 | $-1.50 | $-1.25 | $-1.39 | $-1.52 | $-2.44 | $-3.93 |
| Diluted EPS? | $-1.43 | $-1.07 | $-1.35 | $-1.38 | $-1.50 | $-1.25 | $-1.39 | $-1.52 | $-2.44 | $-3.93 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality